We know having a heart problem or planning for a heart treatment can be stressful. It’s normal for you your family to have many questions and concerns.
We want you to be well informed and at ease with your medical care at the Gill Heart Institute. Our goal is to help you at every stage of your treatment. We do this by answering your questions and telling you what to expect. We also provide the physical and emotional support you need to manage your heart problem.
Your care is based on medical treatments that are proven to be safe and effective. Our approach to your care will focus on you. This means:
• We will help you to improve your health. • We will keep you from staying in the hospital any longer than necessary. • We will help you get back to your normal life more quickly.
If you would like to speak to someone at Gill Heart Institute or if have questions about your care, please call us during office hours at 859-323-0295.
Check out our
Facebook and stay up to date on community events, programs, treatments, research, new physicians and more.
Every year, 900 preventable deaths from cardiovascular disease occur in Kentucky’s 5th congressional district alone, according to one health statistic cited recently by University of Kentucky president Eli Capilouto at the unveiling of UK HealthCare’s new Cardiovascular Inpatient Unit, a 64-bed hub on the eighth floor of Pavilion A at the Chandler Hospital. UK calls the unit one of the largest of its type in the country with 32 intensive care beds and 32 progressive care beds. “It’s a powerful day for the University of Kentucky, but more so for the commonwealth,” Capilouto told the crowd.
Read more »
At 81, Robert Kraus told his doctors he didn’t want a complicated, open-chest procedure to replace his aortic valve. That’s when he learned about a new, minimally invasive procedure now available at UK HealthCare known as TAVR, the latest advancement at the UK Gill Heart Institute.
Read more about Robert’s story and how TAVR helped him quickly return to his normal activities.
Regenerative medicine offers great promise in the development of medical treatments for a wide range of conditions — including heart attacks. A former two-time state amateur golf champ and father of two daughters from Booneville is among those taking part in a clinical trial at Gill Heart Institute that is looking into the possibility that stem cell therapy can repair damaged heart tissue after a recent heart attack.
The University of Kentucky's Health Care Committee of the UK Board of Trustees were presented a strategic plan that will guide UK HealthCare through 2020. The committee met Thursday during their annual retreat.
Clinical trials of PCSK9 inhibitors appear to sharply reduce levels of bad (LDL) cholesterol. Gill Heart Institute's Dr. Thomas Whayne is optimistic that the drugs will be approved by the FDA, but sees some barriers to PCSK9 inhibitors' success.
UK HealthCare's Gill Heart Institute has named Dr. Gretchen Wells as its new Director of Women’s Heart Health.
Medicines can be an effective option for heart failure patients. But if the heart is very weak, a mechanical device that helps a weakened heart pump blood throughout the body, called a VAD, can be a lifesaver.
Researchers at the University of Kentucky's Gill Heart Institute have been awarded a four year, $2.85 million grant from the National Heart Lung and Blood Institute to study the mechanisms by which diet and family history increase the risk of heart attacks.
UK HealthCare's Gill Heart Institute has received the "Get With The Guidelines-Resuscitation Gold Quality Achievement Award" for maintaining specific quality measures outlined by the American Heart Association for the treatment of patients who suffer cardiac arrests in the hospital.
Put on your walking shoes and join the Gill Heart Institute' cardiologist Dr. Alison Bailey for the 2015 Walk with a Doc season.
Coffee, without a doubt, has secured itself in the hearts of many. But is your heart loving it back?
Xiang-An Li, Ph.D., of the University of Kentucky Saha Cardiovascular Research Center and Department of Pediatrics, has been awarded a $3 million grant from the National Institutes of Health to study synthetic HDL (sHDL) as a potential therapy for sepsis.
The Gill Heart Institute at the University of Kentucky is one of 40 centers in the U.S. participating in this landmark clinical trial.
In its infancy, echocardiography (ECHO) was merely a diagnostic tool. Today, ECHO helps patients every step of the way from diagnosis to post-treatment performance metrics -- and provides cardiologists at the Gill Heart Institute the information they need to help doctors and their patients all over Kentucky.
When Jon Wes Adams collapsed from sudden cardiac arrest last summer, bystanders performed a new technique called Hands-Only CPR that kept him alive until he could get the proper treatment. But no one anticipated that it would ultimately save his identical twin's life too.
Dr. Maya Guglin, director of mechanical assisted circulation at the University of Kentucky's Gill Heart Institute, has launched The VAD Journal, a publication focused exclusively on mechanical assisted circulation.
Today marks the unveiling of UK HealthCare's new Cardiovascular Inpatient Unit. The 64-bed inpatient unit, on the 8th floor of the Albert B. Chandler Hospital's new Pavilion A, is one of the largest cardiovascular intensive care units in the country. Patients will transition to the new unit on Dec. 7.
Clark Regional Medical Center (CRMC) is now an affiliate in the UK Gill Heart Institute Affiliate Network and also has entered into a formal collaboration with the UK Markey Cancer Center to develop its oncology service line.
Preparations for the opening of the Gill Heart Institute's new inpatient unit are at a fever pitch, with legions of construction workers coordinating with UK Facilities Planning staff to complete fit-out of UK Chandler Hospital's 8th floor before its scheduled opening in December.
On Oct. 17, the Lexington Convention Center featured more than 200 students and scientists sharing their latest research on cardiovascular health for the 17th annual Gill Heart Institute Cardiovascular Research Day.
On Friday, Oct. 24, UK HealthCare will host a special symposium to mark a major anniversary: 50 years of transplantation. The UK Transplant Center is celebrating its five decades of transplant innovation, expertise and patient-centered compassionate care at UK with presentations by some of the top transplant specialist in the country.
Jarrett Spriggs was moved to make some dramatic lifestyle changes after a rare cardiovascular emergency brought him to UK Chandler Hospital in May. In December, the hospital will open a new cardiovascular unit featuring interactive technologies to help patients along the road to recovery and improved heart health.
The UK HealthCare Gill Heart Institute's Cardiac Rehabilitation Program has received recertification from the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR).
A group of researchers led by Sidney "Wally" Whiteheart, PhD, at the University of Kentucky, has published findings from an important study exploring the role that a gene called STXBP5 plays in the development of cardiovascular disease.
Mike Graham was scuba diving one day when suddenly he could not catch his breath. Pulmonary rehabilitation has allowed him to return to many of the activities he enjoyed before he was diagnosed with COPD
The University of Kentucky has been awarded research grants totaling $1.26 million by the American Heart Association.
The University of Kentucky's Gill Heart Institute, Manchester Memorial Hospital (MMH), and ARH Cardiology Associates have partnered to offer Clay County and surrounding areas access to advanced cardiology services.
The Division of Cardiovascular Medicine sponsors a weekly continuing education series. Seminars are held Fridays from 7:30-8:30 a.m. in room 234 of the Biological-Pharmaceutical Complex. Please contact the host if you wish to have lunch with or meet the speaker during his or her time on campus.
Gill Heart Institute | Directions » 1000 S. Limestone Lexington KY 40536 859-323-5000
Cardiac Rehabilitation and Wellness | Directions » 125 E. Maxwell St. Lexington KY 40508 859-257-1000
Additional locations »
The UK Gill Heart Institute is at a critical point in the history of medicine and health care. Advances in technology and science offer unprecedented opportunities to reduce suffering, save lives and cure disease. As the only academic health care system that serves Central and Eastern Kentucky, the Gill combines world-class clinical care with leading-edge cardiovascular research and outstanding medical education. Compassionate and knowledgeable specialists collaborate to treat each patient as an individual and work in virtually every area of cardiology. The Gill Heart Institute is here for you.
Gill’s generous donors have provided the margin of excellence to our clinical, research and educational programs that train future medical professionals. Donor support helps us build state-of-the-art facilities, purchase the latest technology and provide outreach to communities in distant counties. Any amount is welcome. Donors may direct their donations to any service or program they desire, or they can donate in honor of an individual.
Become a partner in this effort to keep the UK Gill Heart Institute a regional and national pacesetter. Working together, we can transform the future of health care for the Commonwealth well into the 21st century.
To make a donation, please visit our secure online giving form or call 859-257-1000 or toll free 1-800-333-8874.
Local residents thankful for heart care close to home
(View PDF, 326 KB)